Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
Fish and Richardson
Federal Trade Commission
Farmers Insurance

Generated: December 11, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 019001

« Back to Dashboard

NDA 019001 describes BEPADIN, which is a drug marketed by Medpointe Pharm Hlc and is included in one NDA. Additional details are available on the BEPADIN profile page.

The generic ingredient in BEPADIN is bepridil hydrochloride. There are four drug master file entries for this compound. Additional details are available on the bepridil hydrochloride profile page.

Summary for 019001

Formulation / Manufacturing:see details

Medical Subject Heading (MeSH) Categories for 019001

Summary for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength200MG
Approval Date:Dec 28, 1990TE:RLD:No

Summary for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength300MG
Approval Date:Dec 28, 1990TE:RLD:No

Summary for product number 003

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength400MG
Approval Date:Dec 28, 1990TE:RLD:No

Expired Orange Book Patents for NDA: 019001

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Medpointe Pharm HlcBEPADINbepridil hydrochlorideTABLET;ORAL019001-001Dec 28, 1990► Subscribe► Subscribe
Medpointe Pharm HlcBEPADINbepridil hydrochlorideTABLET;ORAL019001-003Dec 28, 1990► Subscribe► Subscribe
Medpointe Pharm HlcBEPADINbepridil hydrochlorideTABLET;ORAL019001-002Dec 28, 1990► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
Daiichi Sankyo
Johnson and Johnson
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch: